CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 70 filers reported holding CARA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $444,000 | -38.8% | 27,533 | -30.7% | 0.00% | -40.0% |
Q3 2019 | $726,000 | -22.0% | 39,720 | -8.2% | 0.01% | -28.6% |
Q2 2019 | $931,000 | +7.6% | 43,247 | -2.0% | 0.01% | 0.0% |
Q1 2019 | $865,000 | +75.1% | 44,131 | +16.0% | 0.01% | +75.0% |
Q4 2018 | $494,000 | +88.5% | 38,033 | +247.4% | 0.00% | +100.0% |
Q3 2018 | $262,000 | +482.2% | 10,948 | +198.0% | 0.00% | – |
Q2 2018 | $45,000 | 0.0% | 3,674 | 0.0% | 0.00% | – |
Q1 2018 | $45,000 | +9.8% | 3,674 | +11.1% | 0.00% | – |
Q4 2017 | $41,000 | -6.8% | 3,308 | +4.7% | 0.00% | – |
Q3 2017 | $44,000 | +22.2% | 3,158 | +33.4% | 0.00% | – |
Q2 2017 | $36,000 | -62.5% | 2,368 | -54.5% | 0.00% | -100.0% |
Q1 2017 | $96,000 | +2300.0% | 5,208 | +1125.4% | 0.00% | – |
Q4 2016 | $4,000 | +33.3% | 425 | +41.7% | 0.00% | – |
Q3 2016 | $3,000 | +200.0% | 300 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,655,576 | $4,685,280 | 0.73% |
Bain Capital Life Sciences Investors, LLC | 934,898 | $2,645,761 | 0.27% |
FNY Investment Advisers, LLC | 35,000 | $99 | 0.12% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,764,201 | $4,992,689 | 0.11% |
Ergoteles LLC | 358,275 | $1,013,918 | 0.05% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $239,220 | 0.04% |
PDT Partners, LLC | 85,088 | $240,799 | 0.03% |
PINNACLE ASSOCIATES LTD | 672,440 | $1,903,005 | 0.03% |
Alpine Global Management, LLC | 34,014 | $96,260 | 0.03% |
XTX Topco Ltd | 52,025 | $147,231 | 0.03% |